生命科学资讯

Harbour BioMed docks with BMS in antibody discovery, development deal worth up to $1.1B

Medtronic rolls out new peripheral thrombectomy system while making advances in brain bleeds

Nektar claims phase 2 alopecia success after excluding patients who ‘should never have been enrolled’

December deal flurry rolls on with Genentech-Caris cancer collab worth up to $1.1B

Xoma acquires another struggling biotech, this time zeroing in on Generation Bio

Aldeyra dry eye disease candidate hit by FDA delay amid shifting agency guidance, biotech says

Ramaswamy-backed Ambros Therapeutics launches with $125M to develop pain drug

Siemens Healthineers taps ALZpath for Alzheimer’s blood test biomarker

MapLight brightens SandboxAQ with new deal to discover new CNS candidates

FDA clears Medivis AR headset platform for neurosurgery navigation

Sanofi signs $1B biobucks pact for Alzheimer’s asset in 2nd biotech deal of the day

Pfizer, Sanofi pull out checkbooks for separate year-end autoimmune pacts

Chai infuses AI drug discovery efforts with $130M series B

J&J-backed Link launches with $60M, plan to create next-gen CAR-T therapies

Aviceda geographic atrophy hopeful fails to top Astellas' med in phase 2

Sanofi's tolebrutinib woes pile up with FDA delay, trial miss

Lumexa Imaging tallies $462.5M in IPO, doubling original target

Philips claims AI coronary imaging developer SpectraWAVE

Kyverna gains clear view to first CAR-T approval for autoimmune disease after 'truly remarkable' SPS readout

Beyond the ADC Hype: Innovation is accelerating through bispecifics and dual payload strategies